What is Nephro-Tech?
Established in 1992, Nephro-Tech, Inc. occupies a critical niche in the healthcare sector, focusing on the development and distribution of high-quality pharmaceuticals and dietary supplements tailored for dialysis patients. The company addresses the specific physiological needs of individuals managing chronic kidney disease by providing essential prescription iron supplements and renal vitamins. By prioritizing affordability and convenience, Nephro-Tech has solidified its reputation as a reliable partner for healthcare providers seeking cost-effective, high-efficacy interventions to replenish vital nutrients lost during the dialysis process.
How much funding has Nephro-Tech raised?
Nephro-Tech has raised a total of $79K across 1 funding round:
Debt
$79K
Debt (2021): $79K with participation from PPP
Key Investors in Nephro-Tech
PPP
Public-Private Partnership
What's next for Nephro-Tech?
With the infusion of this recent investment, Nephro-Tech is poised to accelerate its strategic growth initiatives. The company is expected to focus on expanding its product portfolio and optimizing its supply chain to meet the rising demand for renal-specific nutritional support. As the firm transitions through this significant Series B/C stage, the focus will likely shift toward increasing market penetration and strengthening its competitive advantage in the pharmaceutical landscape. This capital deployment will be instrumental in sustaining long-term operational excellence and improving patient outcomes across the dialysis care continuum.
See full Nephro-Tech company page
